IS26-mediated circular blaKPC transposon in ST2483 Pseudomonas aeruginosa
Mingxiao Chen1, Qingqing Zhi2, Miaoshan Luo3
1Clinical Laboratory Medicine Department, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Abstract:
The global spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a critical clinical threat, with blaKPC as a key mobile carbapenem resistance gene. Here, we investigated a novel blaKPC-2 genetic element and its transmission in clinical ST2483 isolate PA100 via whole-genome sequencing, molecular, and phenotypic testing, and vesicle analysis. A unique 4,746-bp IS26-flanked structure inserted at the chromosomal InaA/pncB2 locus was confirmed, which forms a circular transposition intermediate through IS26 recombination. PA100 exhibited ~40-fold higher blaKPC-2 copy number and ~25-fold higher mRNA expression vs chromosomal blaKPC-2 strain PA3; meropenem exposure further elevated its transcription by nearly 70-fold, far exceeding controls. PA100 showed an extensively drug-resistant phenotype with high-level carbapenem resistance, while remaining susceptible to ceftazidime-avibactam and cefiderocol. No classical conjugation or transformation was observed, while intact outer membrane vesicles (OMVs) from PA100 carried blaKPC-2, supporting a non-plasmid, vesicle-associated route for transient delivery of the resistance gene under the tested conditions. The circular transposon remained genetically stable after 10 generations of passaging in PA100; however, stable maintenance in the PAO1 recipient was not detected after passage. In summary, we first report an IS26-driven circular blaKPC-2 transposon in ST2483 P. aeruginosa, conferring robust overexpression and stable inheritance in the donor strain, with OMVs potentially facilitating its horizontal spread, although stable maintenance in recipient cells was not demonstrated under the current assay conditions. These data advance understanding of blaKPC dissemination in CRPA and highlight clinical surveillance priorities for rare high-risk sequence types.
Insights
A novel genetic element carrying the carbapenem resistance gene blaKPC-2 was identified in Pseudomonas aeruginosa. Outer membrane vesicles may facilitate its spread, posing a significant clinical threat.
Area of Science:
- Microbiology
- Genetics
- Antimicrobial Resistance
Background:
- Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major global health concern.
- The blaKPC gene is a primary driver of carbapenem resistance in CRPA.
- Understanding novel resistance mechanisms is crucial for combating CRPA spread.
Purpose of the Study:
- To investigate a novel blaKPC-2 genetic element and its transmission in a clinical ST2483 CRPA isolate.
- To elucidate the mechanism of blaKPC-2 gene amplification and expression.
- To determine the role of outer membrane vesicles (OMVs) in blaKPC-2 dissemination.
Main Methods:
- Whole-genome sequencing of CRPA isolate PA100.
- Molecular and phenotypic testing for drug resistance.
- Analysis of transposition intermediates and OMVs.
- Gene expression and copy number quantification.
- Bacterial passaging experiments.
Main Results:
- A unique IS26-flanked structure containing blaKPC-2 was identified at the InaA/pncB2 locus.
- PA100 exhibited significantly increased blaKPC-2 copy number and mRNA expression, leading to high-level carbapenem resistance.
- OMVs from PA100 carried blaKPC-2, suggesting a vesicle-associated horizontal gene transfer route.
- The circular transposon was stable in the donor strain but not stably maintained in the recipient strain after passage.
Conclusions:
- First report of an IS26-driven circular blaKPC-2 transposon in ST2483 P. aeruginosa.
- The element confers robust blaKPC-2 overexpression and stable inheritance in the donor.
- OMVs may facilitate horizontal spread of blaKPC-2, though stable recipient maintenance requires further study.
- Findings highlight the need for clinical surveillance of high-risk CRPA strains.
Related Concept Videos
Transposons
piRNA - Piwi-interacting RNAs
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Conjugation


